Mar 14, 2024 / 12:30PM GMT
Operator
And good morning and good morning, and welcome to the Q4 and fiscal 2023 financial results conference call for HLS Therapeutics.
On this morning's call, we have Craig Millian, Chief Executive Officer, and John Hanna, Interim Chief Financial Officer. (Operator Instructions)
Earlier this morning, HLS issued a news release announcing its financial results for the three and 12 months ended December 31, 2023. This news release, along with the company's MD&A and financial statements, are available on HLS.' website and on SEDAR.
Please note that slides accompanying today's call can be viewed via the webcast, a link to which is available in the company's earnings press release and at its website.
On the events page, certain matters discussed in today's conference call or answers that may be given to close questions could constitute forward-looking statements. Actual results could differ materially from those anticipated risk factors that could affect results are detailed in the Company's annual information form, which has been filed on CEDAR plus at w. w. w. CEDAR plus
Q4 2023 HLS Therapeutics Inc Earnings Call Transcript
Mar 15, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers